Recorded Future
N2- Location
- Tokyo
- Posted
Business level. The bar most bilingual roles set: meetings, email and documents in Japanese.
Veeva Systems
Tokyo
Veeva Systems is a mission-driven organization and pioneer in industry cloud, helping life sciences companies bring therapies to patients faster. As one of the fastest-growing SaaS companies in history, we surpassed $3B in revenue in our last fiscal year with extensive growth potential ahead.
At the heart of Veeva are our values: Do the Right Thing, Customer Success, Employee Success, and Speed. We're not just any public company – we made history in 2021 by becoming a public benefit corporation (PBC), legally bound to balancing the interests of customers, employees, society, and investors.
Join us in transforming the life sciences industry, committed to making a positive impact on its customers, employees, and communities.
The Role
This Director role requires a deep understanding of the global life sciences safety/Pharmacovigilance operations space and the associated safety applications used to collect, process, report, and determine the safety profile of a pharmaceutical product. This role will be responsible for growing Veeva’s Safety market share in Japan. In this role, you will have the opportunity to work with a team of Life Sciences industry and technology A-players, who, together, are bringing the next generation of Safety applications and capabilities to the life sciences industry.
Veeva’s headquarters is located in the San Francisco Bay Area with offices in more than 15 countries around the world.
Veeva is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, sex, sexual orientation, gender identity or expression, religion, national origin or ancestry, age, disability, marital status, pregnancy, protected veteran status, protected genetic information, political affiliation, or any other characteristics protected by local laws, regulations, or ordinances.
Last checked Nov 3, 2026